Study of prognostic splicing factors in cancer using machine learning approaches
Human Molecular Genetics · 2024
DOI: 10.1093/hmg/ddae047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2024. Verfasst von Mengyuan Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Zhengzhou University, No. 100, Kexue Avenue, Zhengzhou, Henan 450001, China. Hauptthemen laut MEDLINE: RNA Splicing Factors, Machine Learning, Alternative Splicing, Neoplasms. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Splicing factors (SFs) are the major RNA-binding proteins (RBPs) and key molecules that regulate the splicing of mRNA molecules through binding to mRNAs. The expression of splicing factors is frequently deregulated in different cancer types, causing the generation of oncogenic proteins involved in cancer hallmarks. In this study, we investigated the genes that encode RNA-binding proteins and identified potential splicing factors that contribute to the aberrant splicing applying a random forest classification model. The result suggested 56 splicing factors were related to the prognosis of 13 cancers, two SF complexes in liver hepatocellular carcinoma, and one SF complex in esophageal carcinoma. Further systematic bioinformatics studies on these cancer prognostic splicing factors and their related alternative splicing events revealed the potential regulations in a cancer-specific manner. Our analysis found high ILF2-ILF3 expression correlates with poor prognosis in LIHC through alternative splicing. These findings emphasize the importance of SFs as potential indicators for prognosis or targets for therapeutic interventions. Their roles in cancer exhibit complexity and are contingent upon the specific context in which they operate. This recognition further underscores the need for a comprehensive understanding and exploration of the role of SFs in different types of cancer, paving the way for their potential utilization in prognostic assessments and the development of targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Zhengzhou University, No. 100, Kexue Avenue, Zhengzhou, Henan 450001, China.
- Center for Computational Systems Medicine, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, 7000 Fannin St Suite 600, Houston, Texas 77030, United States.
- McGovern Medical School, The University of Texas Health Science Center at Houston, 6431 Fannin St, Houston, Texas 77030, United States.
- School of Dentistry, The University of Texas Health Science Center at Houston, 7500 Cambridge St, Houston, Texas 77054, United States.
ORCID-Profile: Mengyuan Yang
Förderung
- NIGMS NIH HHS
- NIH HHS
- China Postdoctoral Science Foundation
- National Science Foundation
- NIAMS NIH HHS
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Yang, M., Liu, J., Kim, P., & Zhou, X. (2024). Study of prognostic splicing factors in cancer using machine learning approaches. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae047
Vancouver
Yang M, Liu J, Kim P, Zhou X. Study of prognostic splicing factors in cancer using machine learning approaches. Human Molecular Genetics. 2024. doi:10.1093/hmg/ddae047
BibTeX
@article{Yang2024,
author = {Yang, Mengyuan and Liu, Jiajia and Kim, Pora and Zhou, Xiaobo},
title = {Study of prognostic splicing factors in cancer using machine learning approaches},
journal = {Human Molecular Genetics},
year = {2024},
doi = {10.1093/hmg/ddae047}
}
EUVIMED